| 1 |
Design, synthesis, and biological evaluation of a novel dual peroxisome proliferator-activated receptor alpha/delta agonist for the treatment of diabetic kidney disease through anti-inflammatory mechanisms |
|
| | Kai Liu,Xing Zhao,Xue Qi,Dong-Liang Hou,Hao-Bin Li,Yu-Hao Gu,Qing-Long Xu | | | European Journal of Medicinal Chemistry. 2021; : 113388 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
PPARa Agonist Oral Therapy in Diabetic Retinopathy |
|
| | Yohei Tomita,Deokho Lee,Kazuo Tsubota,Toshihide Kurihara | | | Biomedicines. 2020; 8(10): 433 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Pemafibrate Protects Against Retinal Dysfunction in a Murine Model of Diabetic Retinopathy |
|
| | Yohei Tomita,Deokho Lee,Yukihiro Miwa,Xiaoyan Jiang,Masayuki Ohta,Kazuo Tsubota,Toshihide Kurihara | | | International Journal of Molecular Sciences. 2020; 21(17): 6243 | | | [Pubmed] [Google Scholar] [DOI] | |
|
